EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

CPT1A inhibition alleviates plasmacytoid dendritic cell-mediated immune suppression in colon cancer through fatty acid oxidation modulation

Jing Wu, Shan Zhu, Guoxia Zang, Helei Wang, Ning Yang, Yuan Qiao, Qiuyu Wei, Liyan Wang, Ziyu Ren, Yong-Jun Liu, Jingtao Chen

Journal for ImmunoTherapy of Cancer · 2025-10 · 13 (10) · e012162

DOI: 10.1136/jitc-2025-012162 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 23.10.2025. Verfasst von Jing Wu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Center, The First Hospital of Jilin University, Changchun, China. Hauptthemen laut MEDLINE: Dendritic Cells, Colonic Neoplasms, Carnitine O-Palmitoyltransferase, Fatty Acids. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Scientific and Technological Developing Plan of Jilin Province, the 4th National Natural Science Foundation of China Continuously Supported Fund, Jilin Provincial Department of Education Scientific Research Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The tolerization of plasmacytoid dendritic cells (pDCs) within the tumor microenvironment facilitates immune evasion, thereby significantly limiting the efficacy of cancer immunotherapy. Metabolic regulators are crucial in determining immune cell fate. However, the specific metabolic modifications influencing tumor-associated pDCs (TA-pDCs) are largely uncharacterized.

Methods

We isolated TA-pDCs from patients with colon cancer and mouse models for RNA sequencing detection and immunofluorescence staining. Further, in vitro and in vivo models of colon cancer were used to explore the underlying mechanisms of the fatty acid oxidation (FAO) regulatory pathway of TA-pDCs and its immunosuppressive function.

Results

Peroxisome proliferator-activated receptor gamma pathway promotes FAO in TA-pDCs by upregulating the expression of carnitine palmitoyltransferase-1A (CPT1A). The inhibition of CPT1A significantly reduced the immunosuppressive checkpoint inducible co-stimulator ligand (ICOSL) and increased the levels of the immune-activating protein OX40L and pro-inflammatory cytokines interferon-α and tumor necrosis factor-α. These alterations enhanced CD8 + T-cell functionality and diminished the generation of regulatory T cells, thereby bolstering antitumor immunity. The efficacy of combined immunotherapy using anti-ICOSL and anti-programmed cell death 1-ligand 1 antibodies was markedly improved in murine models of colon cancer.

Conclusions

These findings elucidate the molecular mechanism of CPT1A-mediated FAO in TA-pDCs and its implications in immune evasion, suggesting a novel therapeutic strategy for colon cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dendritic CellsColonic NeoplasmsCarnitine O-PalmitoyltransferaseFatty AcidsAnimalsMiceHumansOxidation-ReductionTumor MicroenvironmentFemaleMice, Inbred C57BL

Stichwörter der Autor:innen

Colon CancerDendriticImmunosuppressionImmunotherapyTolerance

Substanzen

Carnitine O-PalmitoyltransferaseFatty AcidsCPT1A protein, human

Autor:innen und Institutionen

  • Cancer Center, The First Hospital of Jilin University, Changchun, China.
  • Laboratory for Tumor Immunology, The First Hospital of Jilin University, Changchun, China.
  • Department of Stomach Colorectal Anal Surgery, The First Hospital of Jilin University, Changchun, China.
  • Cancer Center, The First Hospital of Jilin University, Changchun, China jtchen@jlu.edu.cn.

Förderung

  • Scientific and Technological Developing Plan of Jilin Province
  • the 4th National Natural Science Foundation of China Continuously Supported Fund
  • Jilin Provincial Department of Education Scientific Research Project
  • National Natural Science Foundation of China

Zitieren

APA

Wu, J., Zhu, S., Zang, G., Wang, H., Yang, N., Qiao, Y., Wei, Q., Wang, L., Ren, Z., Liu, Y. J., & Chen, J. (2025). CPT1A inhibition alleviates plasmacytoid dendritic cell-mediated immune suppression in colon cancer through fatty acid oxidation modulation. Journal for ImmunoTherapy of Cancer, 13(10), e012162. https://doi.org/10.1136/jitc-2025-012162

Vancouver

Wu J, Zhu S, Zang G, Wang H, Yang N, Qiao Y, et al. CPT1A inhibition alleviates plasmacytoid dendritic cell-mediated immune suppression in colon cancer through fatty acid oxidation modulation. Journal for ImmunoTherapy of Cancer. 2025;13(10):e012162. doi:10.1136/jitc-2025-012162

BibTeX
@article{Wu2025,
  author = {Wu, Jing and Zhu, Shan and Zang, Guoxia and Wang, Helei and Yang, Ning and Qiao, Yuan and Wei, Qiuyu and Wang, Liyan and Ren, Ziyu and Liu, Yong-Jun and Chen, Jingtao},
  title = {CPT1A inhibition alleviates plasmacytoid dendritic cell-mediated immune suppression in colon cancer through fatty acid oxidation modulation},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2025},
  volume = {13},
  number = {10},
  pages = {e012162},
  doi = {10.1136/jitc-2025-012162}
}
Kostenlos starten →